Objective To evaluate the performance of a newly developed point-of-care test (POCT) for the detection of measles-specific IgM antibodies in serum and oral fluid specimens and to assess if measles virus nucleic acid could be recovered from used POCT strips.
Introduction
Measles is a severe, vaccine-preventable disease that causes extensive morbidity and mortality in large parts of the world. Despite the widespread use of measles vaccine, either as a single antigen vaccine or as a component of the triple vaccine against measles, mumps and rubella (MMR), 278 358 reported cases of measles and an estimated 164 000 deaths from measles occurred worldwide in 2008. 1 Vaccine coverage is highly variable between World Health Organization (WHO) global regions.
Measles has been eliminated in the Americas but continues to be endemic in the African and South-East Asia regions, where vaccine coverage is less than 80%. These regions account for approximately 94% of all global measles deaths. 1 Outbreaks continue to occur in other global regions, primarily as a result of measles virus importation into areas where vaccine coverage has fallen to a suboptimal level and a susceptible cohort has accumulated. [2] [3] [4] Most regions have elimination goals and elimination strategies based on the maintenance of high vaccination coverage, for which political commitment is required. A key component of elimination plans is surveillance to monitor impact.
Laboratory confirmation of cases of measles is a vital aspect of surveillance at all stages of control programmes because clinical diagnosis is unreliable. 5 The mainstay of laboratory confirmation is the detection of measles-specific immunoglobulin M (IgM) antibodies in serum samples. 6, 7 More recently, alternative samples such as dried blood spots and oral fluids have been used for diagnosis by antibody detection. Oral fluids can also be used to detect viral ribonucleic acid (RNA) and their use is becoming increasingly common because samples can be obtained safely and non-invasively, without the risks associated with blood collection, and it improves patient compliance with specimen collection, as the procedure is simple and painless. [7] [8] [9] [10] Point-of-care tests (POCTs) are increasingly used for the rapid diagnosis of infections. They can be performed in a single incubation step at ambient temperature without complex electrical equipment and their results can be read visually. By increasing diagnostic capacity and facilitating rapid diagnosis in resource-poor countries, they have the potential to improve measles surveillance and the response of health authorities to possible outbreaks.
We have developed a POCT capable of detecting measles-specific IgM antibodies in both serum and oral fluid specimens. In this paper we describe the Publication: Bulletin of the World Health Organization; Type: Research Article ID: BLT.11.088427 diagnostic performance of this POCT for each specimen type. We also investigated whether viral RNA could be amplified from the used test strips, as that would enhance their use in measles surveillance.
Methods

Test strips
The POCT strips for the detection of measles-specific IgM were constructed essentially as described for mumps-specific IgM POCT strips, 11 except that affinity purified Assembled POCT strips are illustrated in Fig. 1 .
Serum protocol
Recombinant measles virus nucleoprotein (rNP), expressed in yeast Pichia pastoris and purified by caesium chloride ultracentrifugation, 13 was diluted to 3.5 μg/ml in oral fluid extraction diluent, prepared as described previously.
14 A cut-off serum giving a weakly reactive anti-human IgM antibody test line signal in the POCT was prepared. This was done by diluting one part of a serum that tested positive for measles IgM on capture enzyme immunoassay (EIA) in 20 parts of a measles-IgM-negative human serum. The cut-off serum was tested in parallel with patient sera.
The cut-off serum and patient sera were diluted 1 part in 100 in oral fluid extraction diluent and 100 μl of the resulting dilution were mixed with 5 μl of the 3.5 μg/ml rNP in a plastic tube. POCT strips were inserted in the serum-rNP mixture to initiate the flow of reagents and were incubated at room temperature for 10 minutes.
Test results were interpreted by comparing the intensity of the pink to red signal generated at the test line with patient sera with that of the signal generated with the cutoff serum run in parallel. If the test line signal was more intense in colour than the signal obtained with the cut-off serum, the test was considered positive; if the test line signal was less intense in colour than the signal obtained with the cut-off serum or if both signals were equally intense in colour, the test was considered negative (Fig. 1) . 
Virus nucleic acid amplification
An additional 24 oral fluid specimens received for measles surveillance testing in September 2010 were used to evaluate the extraction and amplification of viral genome from POCT strips after IgM detection. Following routine surveillance testing, the specimens were stored for up to 6 weeks at 2-8 °C before this evaluation.
To investigate the stability of measles virus nucleic acid on POCT strips, the oral fluids were tested in duplicate by POCT as described earlier, then dried and stored at 20-25 °C. Nucleic acid was extracted and complementary DNA (cDNA) was prepared as described previously, 11 from an aliquot of each oral fluid on the day of point-of-care testing, from one set of dried POCT strips after overnight storage and from a second set of dried strips after 5 weeks of storage. Measles virus cDNA amplicons were generated by real-time polymerase chain reaction (PCR) for the haemagglutinin (H) gene 15 and by nested PCR targeting the nucleocapsid (N) gene. Martens-Latem, Belgium) and genotyped by comparison with reference strain sequences according to WHO guidelines.
17-19
Results
Serum
Concordant results were obtained for 157 (92.4%) of the 170 sera tested by measlesspecific IgM capture EIA and POCT (Table 1) . Of 76 sera that tested positive for measles-specific IgM in EIA, 69 also tested positive by POCT. This included 5 sera that also tested positive for rubella-specific IgM.
Of the 94 sera that tested negative for measles-specific IgM by EIA, 88 were also negative by POCT, including 69 that had tested positive for rubella-specific IgM. Two of the 7 sera that tested positive for measles-specific IgM by capture EIA and negative by POCT had low T/COs (1.5 and 1.9) in the EIA. They had been collected 1 and 5 days, respectively, after the onset of fever. Of 74 sera that tested positive for rubella-specific IgM only, 69 tested negative by the POCT. Thus, with this set of samples the POCT had a specificity of 93.2%.
The overall performance of the POCT with all serum samples was as follows: 
Oral fluid
The performance of the POCT on oral fluids was evaluated using a total of 282 specimens received for measles and rubella investigations ( The POCT data were further analysed as a function of T/CO on EIA and of the timing of specimen collection following the onset of symptoms (Table 3) .
Approximately 20% of the specimens were collected within 7 days of the onset of symptoms; 25% were collected between 7 and 14 days after onset and 31% were collected after the 14th day. The timing of specimen collection in relation to the onset of symptoms was not known for 24% of oral fluids. Seven out of the 70 oral fluids that tested positive by EIA gave discrepant POCT results. All such specimens had T/COs on EIA just above the positive cut-off value of 1.0 (range: 1.05-1.94). Collection dates were known for six of these specimens. Five of them had been collected more than 14 days after the onset of symptoms (range: 19-38). The sixth oral fluid had been collected three days after the onset of symptoms. However, this patient had also received a single dose of measles-virus containing vaccine 32 days before the specimen was collected. (Table 4) . In this case, measles was confirmed by PCR. specimens with an EIA T/CO greater than 5 were identified (Table 3) . However, one oral fluid specimen, number 19 in Table 4 , was highly reactive in the measles-specific 
Stability of measles nucleic acid on POCT strips
